Cite
HARVARD Citation
Arzimanoglou, A. et al. (n.d.). Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study. European journal of paediatric neurology. pp. 393-402. [Online].